WAVE Life Sciences (WVE) News Today $6.38 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$6.34 -0.04 (-0.71%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock WVE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Should WVE-006’s RNA-Editing AAT Data Shift the Risk-Reward Calculus for Wave Life Sciences (WVE) Investors?May 25 at 1:54 PM | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Gossamer Bio (GOSS) and Cullinan Management (CGEM)May 21, 2026 | theglobeandmail.comWhat is HC Wainwright's Forecast for WVE FY2028 Earnings?May 21, 2026 | marketbeat.comWave Life Sciences: 'Strong Buy' On DMD NDA Filing WVE-N531 And Released AATD DataMay 20, 2026 | seekingalpha.comWVE stock edges up after positive early data for rare disease drugMay 20, 2026 | msn.comFinancial Comparison: Tarsus Pharmaceuticals (NASDAQ:TARS) versus WAVE Life Sciences (NASDAQ:WVE)May 20, 2026 | americanbankingnews.comWave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1May 19, 2026 | prnewswire.comWave Life Sciences Ltd. (WVE) Shareholder/Analyst Call TranscriptMay 19, 2026 | seekingalpha.comWave Life Sciences Ltd. (WVE) Shareholder/Analyst Call - SlideshowMay 18, 2026 | seekingalpha.comWave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly DosingMay 18, 2026 | globenewswire.comWave Life Sciences (WVE) price target decreased by 15.26% to 23.97May 15, 2026 | msn.comWave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare ConferenceMay 13, 2026 | globenewswire.comGrowth Investors: Industry Analysts Just Upgraded Their Wave Life Sciences Ltd. (NASDAQ:WVE) Revenue Forecasts By 91%May 8, 2026 | finance.yahoo.comWave Life Sciences: Good Platform, Mixed Clinical Trial Data, HoldMay 7, 2026 | seekingalpha.comHC Wainwright Expects Higher Earnings for WAVE Life SciencesMay 4, 2026 | marketbeat.comCanaccord Genuity Reaffirms Their Buy Rating on Wave Life Sciences (WVE)May 3, 2026 | theglobeandmail.comA Look At Wave Life Sciences (WVE) Valuation After Sharp Year To Date Share Price DeclineMay 3, 2026 | finance.yahoo.comPictet Asset Management Holding SA Purchases 790,175 Shares of WAVE Life Sciences Ltd. $WVEMay 2, 2026 | marketbeat.comWAVE Life Sciences (NASDAQ:WVE) Upgraded to "Hold" at Wall Street ZenMay 2, 2026 | marketbeat.comWAVE Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of "Moderate Buy" by AnalystsMay 2, 2026 | marketbeat.comWAVE Life Sciences (NASDAQ:WVE) Given New $43.00 Price Target at Canaccord Genuity GroupApril 30, 2026 | marketbeat.comWAVE Life Sciences Ltd (WVE) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...April 29, 2026 | finance.yahoo.comWAVE Life Sciences (NASDAQ:WVE) Shares Down 7.6% - Here's What HappenedApril 29, 2026 | marketbeat.comWAVE Life Sciences (NASDAQ:WVE) Posts Quarterly Earnings Results, Beats Expectations By $0.21 EPSApril 29, 2026 | marketbeat.comWAVE Life Sciences Q1 Earnings Call HighlightsApril 28, 2026 | marketbeat.comWAVE Life Sciences (NASDAQ:WVE) Trading 5.5% Higher - Time to Buy?April 28, 2026 | marketbeat.comWave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business UpdateApril 28, 2026 | globenewswire.comWave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026April 22, 2026 | globenewswire.comWave Life Sciences Announces Hearing on Proposed Redomiciliation to the United StatesApril 21, 2026 | globenewswire.comH.C. Wainwright Highlight Misread Risk in Wave Life Sciences Ltd. (WVE) Clinical Data ReactionApril 20, 2026 | insidermonkey.comA Look At Wave Life Sciences (WVE) Valuation After Recent Share Price VolatilityApril 20, 2026 | finance.yahoo.comWave Life Sciences Announces Proposed Redomiciliation to the United StatesApril 15, 2026 | globenewswire.comRBC Capital Maintains Outperform Rating on Wave Life Sciences (WVE)April 12, 2026 | insidermonkey.comWave Life Sciences (WVE) price target decreased by 20.34% to 28.29April 10, 2026 | msn.comWave Life Sciences (WVE) Receives a Buy from Wells FargoApril 2, 2026 | theglobeandmail.comWave Life Sciences Ltd. (WVE) PT Increased to $52 at Canaccord Following Pipeline ReviewMarch 31, 2026 | finance.yahoo.comWave Life Sciences Obesity Data Highlights Visceral Fat Focus Over Weight LossMarch 31, 2026 | finance.yahoo.comWave Life Sciences Ltd. (WVE) PT Increased to $52 at Canaccord Following Pipeline ReviewMarch 30, 2026 | insidermonkey.comWave Life Sciences Ltd. (WVE) Discusses Positive Interim Phase I Data from INLIGHT Trial of WVE-007 for Obesity TranscriptMarch 27, 2026 | seekingalpha.comWave Life Sciences Slips as Obesity Data Fails to ConvinceMarch 27, 2026 | 247wallst.comWave Life Sciences crashes 50% as 'body composition' fat-loss drug underwhelmsMarch 26, 2026 | msn.comStock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data DisappointsMarch 26, 2026 | fool.comWave Life Sciences: WVE-007 Data Leaves Biotech Shaken And Stirred (Downgrade)March 26, 2026 | seekingalpha.comWave Life Sciences Ltd. (WVE) Discusses Positive Interim Phase I Data from INLIGHT Trial of WVE-007 for Obesity - SlideshowMarch 26, 2026 | seekingalpha.comWave Life Sciences shares tumble on obesity drug trial dataMarch 26, 2026 | za.investing.comWave Life Sciences crashes 55% as 'body composition' fat-loss drug underwhelmsMarch 26, 2026 | msn.comWave Life Sciences shares plummet on weight loss therapy updateMarch 26, 2026 | proactiveinvestors.comWAVE LIFE SCIENCES Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesMarch 26, 2026 | globenewswire.comWave Life Sciences stock tumbles 30% despite positive trial dataMarch 26, 2026 | za.investing.comWave Life Sciences Says Obesity Drug Improved Body Composition in StudyMarch 26, 2026 | marketwatch.com Get WAVE Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WVE Media Mentions By Week WVE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WVE News Sentiment▼0.070.47▲Average Medical News Sentiment WVE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WVE Articles This Week▼136▲WVE Articles Average Week Get the Latest News and Ratings for WVE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for WAVE Life Sciences and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies LEGN News APGE News DNTH News CRSP News INDV News KNSA News NAMS News TVTX News CRNX News CPRX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WVE) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WAVE Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share WAVE Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
